Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Izurieta, Hector S."'
Autor:
Izurieta, Hector S, Graham, David J, Jiao, Yixin, Hu, Mao, Lu, Yun, Wu, Yue, Chillarige, Yoganand, Wernecke, Michael, Menis, Mikhail, Pratt, Douglas, Kelman, Jeffrey, Forshee, Richard
Publikováno v:
The Journal of Infectious Diseases
The current study was performed to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) outcomes among Medicare beneficiaries during the pandemic's early phase.In a retrospective cohort study covering Medicare fee-for-service benefici
Autor:
Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Jiao Y; Acumen LLC, Burlingame, California, USA., Graham DJ; Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wu Y; Acumen LLC, Burlingame, California, USA., Wang J; Acumen LLC, Burlingame, California, USA., Menis M; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Chillarige Y; Acumen LLC, Burlingame, California, USA., Wernecke M; Acumen LLC, Burlingame, California, USA., Kelman J; Centers for Medicare and Medicaid Services, Washington, District of Columbia, USA., Forshee RA; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Feb 15; Vol. 225 (4), pp. 567-577.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Lu M; Acumen LLC, Burlingame, California, USA., Kelman J; Centers for Medicare and Medicaid Services, Washington, DC, USA., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Lindaas A; Acumen LLC, Burlingame, California, USA., Loc J; Acumen LLC, Burlingame, California, USA., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wei Y; Acumen LLC, Burlingame, California, USA., Chillarige Y; Acumen LLC, Burlingame, California, USA., Wernecke M; Acumen LLC, Burlingame, California, USA., MaCurdy TE; Acumen LLC, Burlingame, California, USA.; Stanford University Department of Economics, Stanford, California, USA., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Dec 06; Vol. 73 (11), pp. e4251-e4259.
Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Wu X; Acumen LLC, Burlingame, California, USA., Forshee R; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Lu Y; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Sung HM; Acumen LLC, Burlingame, California, USA., Agger PE; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Chillarige Y; Acumen LLC, Burlingame, California, USA., Link-Gelles R; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lufkin B; Acumen LLC, Burlingame, California, USA., Wernecke M; Acumen LLC, Burlingame, California, USA., MaCurdy TE; Acumen LLC, Burlingame, California, USA.; Centers for Medicare & Medicaid Services, Washington, DC, USA., Kelman J; Centers for Medicare & Medicaid Services, Washington, DC, USA., Dooling K; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Department of Economics, Stanford University, Stanford, California, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 15; Vol. 73 (6), pp. 941-948.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Graham DJ; Center for Drugs Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Jiao Y; Acumen, LLC, Burlingame, California, USA., Hu M; Acumen, LLC, Burlingame, California, USA., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wu Y; Acumen, LLC, Burlingame, California, USA., Chillarige Y; Acumen, LLC, Burlingame, California, USA., Wernecke M; Acumen, LLC, Burlingame, California, USA., Menis M; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Kelman J; Centers for Medicare $ Medicaid Services, Washington, DC, USA., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2021 Mar 29; Vol. 223 (6), pp. 945-956.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Chillarige Y; Acumen LLC, Burlingame, California, USA., Kelman J; Centers for Medicare and Medicaid Services, Washington District of Columbia, USA., Wei Y; Acumen LLC, Burlingame, California, USA., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Xu W; Acumen LLC, Burlingame, California, USA., Lu M; Acumen LLC, Burlingame, California, USA., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Wernecke M; Acumen LLC, Burlingame, California, USA., MaCurdy T; Acumen LLC, Burlingame, California, USA.; Stanford University Department of Economics, Stanford, California, USA., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Jun 29; Vol. 222 (2), pp. 278-287.
Autor:
Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Chillarige Y; Acumen, Burlingame., Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.; Universidad Rey Juan Carlos, Madrid, Spain., Wei Y; Acumen, Burlingame., Xu W; Acumen, Burlingame., Lu M; Acumen, Burlingame., Sung HM; Acumen, Burlingame., Lindaas A; Acumen, Burlingame., Wernecke M; Acumen, Burlingame., Macurdy T; Acumen, Burlingame.; Department of Economics, Stanford University, Stanford, California., Kelman J; Centers for Medicare and Medicaid Services, Washington, D. C., Forshee RA; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Jan 01; Vol. 221 (1), pp. 168.
Autor:
Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Chillarige Y; Acumen, Burlingame, Stanford University, Stanford, California., Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.; Universidad Rey Juan Carlos, Madrid, Spain., Wei Y; Acumen, Burlingame, Stanford University, Stanford, California., Xu W; Acumen, Burlingame, Stanford University, Stanford, California., Lu M; Acumen, Burlingame, Stanford University, Stanford, California., Sung HM; Acumen, Burlingame, Stanford University, Stanford, California., Lindaas A; Acumen, Burlingame, Stanford University, Stanford, California., Wernecke M; Acumen, Burlingame, Stanford University, Stanford, California., Macurdy T; Acumen, Burlingame, Stanford University, Stanford, California.; Department of Economics, Stanford University, Stanford, California., Kelman J; Centers for Medicare and Medicaid Services, Washington, D. C., Forshee RA; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Sep 26; Vol. 220 (9), pp. 1511-1520.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.; Department of Epidemiology, Universidad Rey Juan Carlos, Spain., Chillarige Y; Acumen, Burlingame, California., Kelman J; Centers for Medicare & Medicaid Services, Washington DC., Wei Y; Acumen, Burlingame, California., Lu Y; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Xu W; Acumen, Burlingame, California., Lu M; Acumen, Burlingame, California., Pratt D; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland., Chu S; Centers for Medicare & Medicaid Services, Washington DC., Wernecke M; Acumen, Burlingame, California., MaCurdy T; Acumen, Burlingame, California., Forshee R; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Sep 13; Vol. 220 (8), pp. 1255-1264.
Autor:
Izurieta HS; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.; Universidad Rey Juan Carlos, Madrid, Spain., Chillarige Y; Acumen LLC, Burlingame, California., Kelman JA; Centers for Medicare and Medicaid Services, Washington, D.C., Forshee R; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Qiang Y; Center for Drugs Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Wernecke M; Acumen LLC, Burlingame, California., Ferdinands JM; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Lu Y; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Wei Y; Acumen LLC, Burlingame, California., Xu W; Acumen LLC, Burlingame, California., Lu M; Acumen LLC, Burlingame, California., Fry A; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia., Pratt D; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Shay DK; Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2018 Jul 18; Vol. 67 (3), pp. 378-387.